Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-11 Purchase | 2024-04-15 08:53 am | Acrivon Therapeutics Inc. | ACRV | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 2,353,000 | $8.5 | $20,000,500 | 5,360,858 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-11-27 6:11 pm | N/A 2034-02-28 | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 67,567 | $0 | 67,567 (Direct) | View |
| 2024-03-01 Option Award | 2024-11-27 6:10 pm | N/A 2034-02-28 | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 90,090 | $0 | 90,090 (Direct) | View |
| 2024-03-01 Option Award | 2024-11-27 6:08 pm | N/A 2034-02-28 | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 45,045 | $0 | 45,045 (Direct) | View |
| 2024-03-01 Option Award | 2024-11-27 6:06 pm | N/A 2034-02-28 | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 90,090 | $0 | 90,090 (Direct) | View |
| 2024-03-01 Option Award | 2024-11-27 6:04 pm | N/A 2034-02-28 | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 315,316 | $0 | 315,316 (Direct) | View |
| 2024-11-21 Tax Withholding | 2024-11-25 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 19,910 | $6.44 | 2,659,593 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:32 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $7.92 | 4,535 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:31 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $7.92 | 37,941 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 368 | $7.92 | 26,522 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 402 | $7.92 | 16,961 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $7.92 | 67,871 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:26 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 60,256 | $7.92 | 2,679,503 (Direct) | View |
| 2024-10-17 Tax Withholding | 2024-10-21 4:22 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $7.87 | 38,125 (Direct) | View |
| 2024-10-01 Tax Withholding | 2024-10-03 6:49 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 284 | $6.98 | 38,683 (Direct) | View |
| 2024-08-21 Tax Withholding | 2024-08-23 4:11 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 79,616 | $9.19 | 2,739,759 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:53 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $7.02 | 4,634 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:52 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $7.02 | 38,967 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:52 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Masson Kristina EVP - Business Operations | 490 | $7.02 | 2,819,375 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:51 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 368 | $7.02 | 26,890 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:50 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 402 | $7.02 | 17,363 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:48 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $7.02 | 68,484 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:47 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO | 59,765 | $7.02 | 2,819,375 (Direct) | View |
| 2024-07-17 Tax Withholding | 2024-07-19 4:20 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $7.69 | 39,151 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 5:36 pm | N/A 2034-06-19 | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 20,275 | $0 | 20,275 (Indirect) | View |
| 2024-06-20 Option Award | 2024-06-24 5:28 pm | N/A 2034-06-19 | Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 5:27 pm | N/A 2034-06-19 | Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 5:27 pm | N/A 2034-06-19 | Acrivon Therapeutics Inc. | ACRV | DiRocco Derek Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2024-06-20 Option Award | 2024-06-24 5:26 pm | N/A 2034-06-19 | Acrivon Therapeutics Inc. | ACRV | BAUM CHARLES M Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-21 4:04 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 10,000 | $1.04 | 155,712 (Direct) | View |
| 2024-05-17 Exercise | 2024-05-21 4:04 pm | N/A 2031-01-13 | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 10,000 | $0 | 155,712 (Direct) | View |
| 2024-05-14 Tax Withholding | 2024-05-16 7:05 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $8.36 | 4,733 (Direct) | View |
| 2024-05-14 Tax Withholding | 2024-05-16 7:03 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $8.36 | 39,709 (Direct) | View |
| 2024-05-14 Tax Withholding | 2024-05-16 7:02 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Masson Kristina EVP - Business Operations | 490 | $8.36 | 2,879,630 (Direct) | View |
| 2024-05-14 Tax Withholding | 2024-05-16 7:00 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 368 | $8.36 | 27,258 (Direct) | View |
| 2024-05-14 Tax Withholding | 2024-05-16 6:58 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 402 | $8.36 | 17,765 (Direct) | View |
| 2024-05-14 Tax Withholding | 2024-05-16 6:56 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $8.36 | 59,097 (Direct) | View |
| 2024-05-14 Tax Withholding | 2024-05-16 6:54 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO | 54,918 | $8.36 | 2,879,630 (Direct) | View |
Ownership | 2024-05-16 6:52 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 0 | $0 | 95,328 (Direct) | View |
| 2024-04-17 Tax Withholding | 2024-04-19 4:10 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $10.34 | 39,893 (Direct) | View |
| 2024-04-11 Option Award | 2024-04-15 4:15 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 3,530,000 | $8.5 | 8,340,508 (Indirect) | View |